Related Experiment Video
Updated: Aug 17, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Comparison of different plateletpheresis systems
1Dept. of Transfusion Medicine and Coagulation Physiology, University Hospital Marburg, FRG.
Important criteria for assessing a cell separator are thrombocyte yield, separation efficiency, and purity of the thrombocyte concentrates. Based on a Multicentric Counting Study, in which 12 centers participated, we conclude that it is very difficult to compare the results of the various centers in regard to the separation efficiency. This is especially true for the comparison of different separation procedures. In Marburg we compared three different cell separators of the newest generation: COBE Spectra (n = 71), Fresenius AS-104 (n greater than 1100) and Fenwal CS-3000 TNX (n = 79). The COBE Spectra exhibited the best separation efficiency with the lowest leukocyte contamination (thrombocytes 4.3 x 10(11) (72.2%), leukocytes 0.5 x 10(7)) on the condition that the ACD-blood ratio did not differ more than -15% from the required algorithm. In order to reduce the risk to the donor, the system correspondingly reduces the donor's blood flow, resulting in a longer donation time (on the average 89-100 min). When the ACD ratio was reduced further, a considerable number of spontaneous and sometimes irreversible platelet aggregation occurred, increasing the risk of shortened survival through reduced platelet function. The AS-104 and the modified CS-3000 (TNX) had similar separation efficiencies (approx. 60%). While the platelet concentrates (PC) of the AS-104 almost reached the purity of that from the COBE Spectra, the leukocyte contamination of the CS-3000 PC's was still about four times as high. Other results published show that morphology, in-vitro function and in-vivo survival of thrombocytes collected with the AS-104 are significantly better than those from the CS-3000.(ABSTRACT TRUNCATED AT 250 WORDS)
Important criteria for assessing a cell separator are thrombocyte yield, separation efficiency, and purity of the thrombocyte concentrates. Based on a Multicentric Counting Study, in which 12 centers participated, we conclude that it is very difficult to compare the results of the various centers in regard to the separation efficiency. This is especially true for the comparison of different separation procedures. In Marburg we compared three different cell separators of the newest generation: COBE Spectra (n = 71), Fresenius AS-104 (n greater than 1100) and Fenwal CS-3000 TNX (n = 79). The COBE Spectra exhibited the best separation efficiency with the lowest leukocyte contamination (thrombocytes 4.3 x 10(11) (72.2%), leukocytes 0.5 x 10(7)) on the condition that the ACD-blood ratio did not differ more than -15% from the required algorithm. In order to reduce the risk to the donor, the system correspondingly reduces the donor's blood flow, resulting in a longer donation time (on the average 89-100 min). When the ACD ratio was reduced further, a considerable number of spontaneous and sometimes irreversible platelet aggregation occurred, increasing the risk of shortened survival through reduced platelet function. The AS-104 and the modified CS-3000 (TNX) had similar separation efficiencies (approx. 60%). While the platelet concentrates (PC) of the AS-104 almost reached the purity of that from the COBE Spectra, the leukocyte contamination of the CS-3000 PC's was still about four times as high. Other results published show that morphology, in-vitro function and in-vivo survival of thrombocytes collected with the AS-104 are significantly better than those from the CS-3000.(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024